Graft failure after T cell depleted HLA identical allogeneic bone marrow transplantation: risk factors in leukemic patients. 1993

M Delain, and J Y Cahn, and E Racadot, and M Flesch, and E Plouvier, and M Mercier, and P Tiberghien, and J J Pavy, and M Deschaseaux, and E Deconinck
Service d'Hématologie, Centre Hospitalo-Universitaire, Besancon, France.

In a retrospective analysis of T cell depleted bone marrow transplantation, we have looked at different parameters in order to determine risk-factors of graft-failure after allogeneic bone marrow transplantation for leukemia. Fifty-one patients with acute leukemia or chronic myeloid leukemia have been analysed. For 33 of them, the pretransplant conditioning regimen consisted of fractionated total body irradiation (TBI) at 12 Gy prior to cyclophosphamide (120 mg/kg). The other patients received various reinforced preparative regimens. T-cell depletion consisted of treating marrow cells with pan-T monoclonal antibodies (CD2+CD3 or CD2-CD5-CD7) followed by complement mediated cytolysis. No post-transplant immunosuppressive prophylaxis was administered except for the first nine patients who received Methotrexate alone. In this group of 51 patients, 12 died within 3 months from graft-related complications and 10 developed graft failure (no engraftment or rejection). Among the possible risk factors associated with this failure, two graft-related parameters appeared significant: the number of CFU-GM progenitors and the number of viable T cells injected with the marrow inoculum. No correlation with graft failure was found with other parameters including diagnosis, disease status at transplant, conditioning regimen, age, sex, and CMV status of donor/host pairs. However, the interpretation must remain cautious because of the relatively small samples in each group.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008212 Lymphocyte Depletion Immunosuppression by reduction of circulating lymphocytes or by T-cell depletion of bone marrow. The former may be accomplished in vivo by thoracic duct drainage or administration of antilymphocyte serum. The latter is performed ex vivo on bone marrow before its transplantation. Depletion, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Delain, and J Y Cahn, and E Racadot, and M Flesch, and E Plouvier, and M Mercier, and P Tiberghien, and J J Pavy, and M Deschaseaux, and E Deconinck
September 1988, Bone marrow transplantation,
M Delain, and J Y Cahn, and E Racadot, and M Flesch, and E Plouvier, and M Mercier, and P Tiberghien, and J J Pavy, and M Deschaseaux, and E Deconinck
July 1988, Blood,
M Delain, and J Y Cahn, and E Racadot, and M Flesch, and E Plouvier, and M Mercier, and P Tiberghien, and J J Pavy, and M Deschaseaux, and E Deconinck
February 1987, Transplantation proceedings,
M Delain, and J Y Cahn, and E Racadot, and M Flesch, and E Plouvier, and M Mercier, and P Tiberghien, and J J Pavy, and M Deschaseaux, and E Deconinck
July 2002, Transplantation,
M Delain, and J Y Cahn, and E Racadot, and M Flesch, and E Plouvier, and M Mercier, and P Tiberghien, and J J Pavy, and M Deschaseaux, and E Deconinck
November 1996, Bone marrow transplantation,
M Delain, and J Y Cahn, and E Racadot, and M Flesch, and E Plouvier, and M Mercier, and P Tiberghien, and J J Pavy, and M Deschaseaux, and E Deconinck
January 1995, Blood,
M Delain, and J Y Cahn, and E Racadot, and M Flesch, and E Plouvier, and M Mercier, and P Tiberghien, and J J Pavy, and M Deschaseaux, and E Deconinck
February 1994, Australian and New Zealand journal of medicine,
M Delain, and J Y Cahn, and E Racadot, and M Flesch, and E Plouvier, and M Mercier, and P Tiberghien, and J J Pavy, and M Deschaseaux, and E Deconinck
March 1986, Clinical and experimental immunology,
M Delain, and J Y Cahn, and E Racadot, and M Flesch, and E Plouvier, and M Mercier, and P Tiberghien, and J J Pavy, and M Deschaseaux, and E Deconinck
June 1990, Blood,
M Delain, and J Y Cahn, and E Racadot, and M Flesch, and E Plouvier, and M Mercier, and P Tiberghien, and J J Pavy, and M Deschaseaux, and E Deconinck
April 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
Copied contents to your clipboard!